Issue Date | Title | Author(s) |
1-Sep-2018 | Automated washing of long-term cryopreserved peripheral blood stem cells promotes cell viability and preserves CD34+ cell numbers | Aerts Kaya, Fatima; Koca, Gül; Sharafi, Parisa ; Sayla, Funda Çakmak; Uçkan-Çetinkaya, Duygu; Özdemir, Evren |
Feb-2018 | Clinical findings and mutation analysis of NF1 patients in Turkey | Terzi, Yunus Kasım; Balcı, Sibel Oğuzkan; Anlar, Banu; Varan, Ali; Evans, Sibel Ersoy; Sharafi, Parisa ; Ayter, Şükriye |
2023 | Clinical signs and genetic evaluation of patients with neurofibromatosis type 1 with and without optic pathway gliomas in a center in Turkey | Sharafi, Parisa ; Varan, Ali; Ersoy-Evans, Sibel; Ayter, Şükriye |
2022 | Combined effects of bone morphogenetic protein-7 and mineral trioxide aggregate on the proliferation, migration, and differentiation of human dental pulp stem cells | Eren, Selen Kucukkaya; Zirh, Elham Bahador; Zirh, Selim; Sharafi, Parisa ; Zeybek, Naciye Dilara |
1-Jul-2018 | The effect of parental age on NF1 patients in Turkey | Ersoy, Evans Sibel; Sharafi, Parisa ; Anlar, Banu; Varan, Ali; Yılmaz, Ömer Faruk; Turan, Mustafa ; Ayter, Şükriye |
2020 | Hastalık tedavisinde genetik yaklaşımlar | Sharafi, Parisa |
2019 | Lösemiler ve NF1 ile İlişkili Tümörlerde EVI2A ve EVI2B Genlerinin Rolü | Ayter, Şükriye ; Sharafi, Parisa ; Anlar, Banu; Varan, Ali; Çetin, Mualla |
May-2017 | NF1 Gene Mutations are the Major Molecular Event in Neurofibromatosis-Noonan Syndrome | Sharafi, Parisa ; Anlar, Banu; Ayter, Şükriye |
3-Apr-2018 | Possible modifier genes in the variation of neurofibromatosis type 1 clinical phenotypes | Sharafi, Parisa ; Ayter, Şükriye |
2020 | Yapay Zekâ ve Genetik | Ayter, Şükriye ; Sharafi, Parisa |